AAAAAA
Results: 1-25/271
Authors:
MASON JW
MILLER WC
Citation: Jw. Mason et Wc. Miller, ABBREVIATED AEROSOL THERAPY FOR IMPROVED EFFICIENCY, Journal of aerosol medicine, 11(3), 1998, pp. 127-131
Authors:
STECKEL H
MULLER BW
Citation: H. Steckel et Bw. Muller, METERED-DOSE INHALER ADD-ON DEVICES - AN IN-VITRO EVALUATION OF THE BRONCHOAIR INHALER AND SEVERAL SPACER DEVICES, Journal of aerosol medicine, 11(3), 1998, pp. 133-142
Authors:
MEAKIN BJ
GANDERTON D
PANZA I
VENTURA P
Citation: Bj. Meakin et al., THE EFFECT OF FLOW-RATE ON DRUG-DELIVERY FROM THE PULVINAL, A HIGH-RESISTANCE DRY POWDER INHALER, Journal of aerosol medicine, 11(3), 1998, pp. 143-152
Authors:
LAUBE BL
BENEDICT GW
DOBS AS
Citation: Bl. Laube et al., TIME TO PEAK INSULIN LEVEL, RELATIVE BIOAVAILABILITY, AND EFFECT OF SITE OF DEPOSITION OF NEBULIZED INSULIN IN PATIENTS WITH NONINSULIN-DEPENDENT DIABETES-MELLITUS, Journal of aerosol medicine, 11(3), 1998, pp. 153-173
Authors:
DICKS H
Citation: H. Dicks, THE AEROSOL-SOCIETY DRUG-DELIVERY TO THE LUNGS VIII DECEMBER 15-16, 1997 LONDON, UNITED-KINGDOM - FOREWORD, Journal of aerosol medicine, 11(3), 1998, pp. 175-175
Citation: THE AEROSOL-SOCIETY DRUG-DELIVERY TO THE LUNGS VIII DECEMBER 15-16, 1997 LONDON, UNITED-KINGDOM - ABSTRACTS, Journal of aerosol medicine, 11(3), 1998, pp. 181-191
Authors:
FINLAY WH
STAPLETON KW
ZUBERBUHLER P
Citation: Wh. Finlay et al., VARIATIONS IN PREDICTED REGIONAL LUNG DEPOSITION OF SALBUTAMOL SULFATE BETWEEN 19 NEBULIZER TYPES, Journal of aerosol medicine, 11(2), 1998, pp. 65-80
Authors:
LARSEN KR
SVENDSEN UG
MOLGAARD F
PETERSEN BN
Citation: Kr. Larsen et al., COMPARABILITY OF ALBUTEROL DELIVERED BY A PIEZOELECTRIC DEVICE VERSUSMETERED-DOSE INHALER IN PATIENTS WITH CHRONIC OBSTRUCTIVE AIRWAYS DISEASE, Journal of aerosol medicine, 11(2), 1998, pp. 81-88
THE USE OF OSMOMETRY AS A MEANS OF DETERMINING CHANGES IN DRUG CONCENTRATION DURING JET NEBULIZATION
Authors:
KWONG E
MACNEISH CF
MEISNER D
KELEMEN S
VADAS EB
COATES AL
Citation: E. Kwong et al., THE USE OF OSMOMETRY AS A MEANS OF DETERMINING CHANGES IN DRUG CONCENTRATION DURING JET NEBULIZATION, Journal of aerosol medicine, 11(2), 1998, pp. 89-100
Authors:
COATES AL
MACNEISH CF
LANDS LC
SMOUNTAS A
MEISNER D
KELEMEN S
VADAS EB
Citation: Al. Coates et al., FACTORS INFLUENCING THE RATE OF DRUG OUTPUT DURING THE COURSE OF WET NEBULIZATION, Journal of aerosol medicine, 11(2), 1998, pp. 101-111
Authors:
SMALDONE GC
CRUZRIVERA M
NIKANDER K
Citation: Gc. Smaldone et al., IN-VITRO DETERMINATION OF INHALED MASS AND PARTICLE DISTRIBUTION FOR BUDESONIDE NEBULIZING SUSPENSION, Journal of aerosol medicine, 11(2), 1998, pp. 113-125
Authors:
SCHREIER H
GAGNE L
CONARY JT
LAURIAN G
Citation: H. Schreier et al., SIMULATED LUNG TRANSFECTION BY NEBULIZATION OF LIPOSOME CDNA COMPLEXES USING A CASCADE IMPACTOR SEEDED WITH 2-CFSMEO-CELLS, Journal of aerosol medicine, 11(1), 1998, pp. 1-13
Authors:
RAU JL
ZHU YZ
Citation: Jl. Rau et Yz. Zhu, RESERVOIR DESIGN AND DOSE AVAILABILITY WITH LONG-TERM METERED-DOSE INHALER CORTICOSTEROID USE, Journal of aerosol medicine, 11(1), 1998, pp. 15-26
Authors:
KESAVANATHAN J
BASCOM R
SWIFT DL
Citation: J. Kesavanathan et al., THE EFFECT OF NASAL PASSAGE CHARACTERISTICS ON PARTICLE DEPOSITION, Journal of aerosol medicine, 11(1), 1998, pp. 27-39
Authors:
BRAND P
APP EM
MEYER T
KUR F
MULLER C
DIENEMANN H
REICHART B
FRUHMANN G
HEYDER J
Citation: P. Brand et al., AEROSOL BOLUS DISPERSION IN PATIENTS WITH BRONCHIOLITIS OBLITERANS AFTER HEART-LUNG AND DOUBLE-LUNG TRANSPLANTATION, Journal of aerosol medicine, 11(1), 1998, pp. 41-53
Authors:
BORGSTROM L
Citation: L. Borgstrom, LOCAL VERSUS TOTAL SYSTEMIC BIOAVAILABILITY AS A MEANS TO COMPARE DIFFERENT INHALED FORMULATIONS OF THE SAME SUBSTANCE, Journal of aerosol medicine, 11(1), 1998, pp. 55-63
Authors:
CLARK AR
GONDA I
NEWHOUSE MT
Citation: Ar. Clark et al., TOWARDS MEANINGFUL LABORATORY TESTS FOR EVALUATION OF PHARMACEUTICAL AEROSOLS, Journal of aerosol medicine, 11, 1998, pp. 1-7
Authors:
WEBB J
Citation: J. Webb, IN-VITRO TESTING OF AEROSOLS - WHAT DOES THE FUTURE HOLD, Journal of aerosol medicine, 11, 1998, pp. 9-10
Authors:
BYRON PR
Citation: Pr. Byron, UNITED-STATES PHARMACOPEIA RECOMMENDATIONS FOR THE TESTING OF INHALERS, Journal of aerosol medicine, 11, 1998, pp. 11-12
Authors:
OLSSON B
Citation: B. Olsson, THE REVISION OF THE INHALANDA MONOGRAPH OF THE EUROPEAN PHARMACOPEIA, Journal of aerosol medicine, 11, 1998, pp. 13-16
Authors:
GRAHAM SJ
DUHAIME RM
LEBELLE MJ
SAVARD C
SHANGHAVI BS
WEBB J
Citation: Sj. Graham et al., COMBINED DOSE UNIFORMITY AND PARTICLE-SIZE TESTING - THE CANADIAN EXPERIENCE, Journal of aerosol medicine, 11, 1998, pp. 17-22
Authors:
VELASQUEZ DJ
GABRIO B
Citation: Dj. Velasquez et B. Gabrio, METERED-DOSE INHALER AEROSOL DEPOSITION IN A MODEL OF THE HUMAN RESPIRATORY SYSTEM AND A COMPARISON WITH CLINICAL DEPOSITION STUDIES, Journal of aerosol medicine, 11, 1998, pp. 23-28
Authors:
LEACH CL
Citation: Cl. Leach, RELEVANCE OF RADIOLABELED STEROID INHALATION STUDIES TO CLINICAL OUTCOMES, Journal of aerosol medicine, 11, 1998, pp. 29-34
Authors:
LAUBE BL
JASHNANI R
DALBY RN
Citation: Bl. Laube et al., PREDICTING IN-VIVO LUNG DEPOSITION OF CROMOLYN SODIUM FROM IN-VITRO ESTIMATES, Journal of aerosol medicine, 11, 1998, pp. 35-42
Authors:
THIEL CG
Citation: Cg. Thiel, CAN IN-VITRO PARTICLE-SIZE MEASUREMENTS BE USED TO PREDICT PULMONARY DEPOSITION OF AEROSOL FROM INHALERS, Journal of aerosol medicine, 11, 1998, pp. 43-52